These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21208874)

  • 21. [Bleeding risk in ST-segment elevation myocardial infarction].
    Benamer H; Meftout B; Chevalier B
    Ann Cardiol Angeiol (Paris); 2010 Dec; 59(6):356-61. PubMed ID: 21056406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antithrombotic and thrombolytic therapy for valvular disease: can this guideline apply to Chinese?
    Fu B; Chen H; Dong L
    Chest; 2013 May; 143(5):1513-1514. PubMed ID: 23648923
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical use of thrombolytic agents].
    Laprevote-Heully MC; Lambert H; Larcan A
    Agressologie; 1983 Nov; 24(11):559-65. PubMed ID: 6367511
    [No Abstract]   [Full Text] [Related]  

  • 24. [Bleeding risk related to combined aspirin and other antithrombotic drug use in patients with acute coronary syndrome: prevention and therapy strategies].
    Li XY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Dec; 38(12):1057-9. PubMed ID: 21215136
    [No Abstract]   [Full Text] [Related]  

  • 25. Between a rock and a hard place: weighing thrombotic risk against bleeding complications.
    Hudzik B; Polonski L
    Am J Cardiol; 2013 May; 111(9):1375. PubMed ID: 23622104
    [No Abstract]   [Full Text] [Related]  

  • 26. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.
    Nieuwlaat R; Olsson SB; Lip GY; Camm AJ; Breithardt G; Capucci A; Meeder JG; Prins MH; Lévy S; Crijns HJ;
    Am Heart J; 2007 Jun; 153(6):1006-12. PubMed ID: 17540203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticoagulation for atrial fibrillation patients with CHADS score of 1.
    Lane DA; Lip GY
    J Cardiovasc Electrophysiol; 2010 May; 21(5):508-10. PubMed ID: 20082649
    [No Abstract]   [Full Text] [Related]  

  • 28. Does ambulation modify venous thromboembolism risk in acutely ill medical patients?
    Amin AN; Girard F; Samama MM
    Thromb Haemost; 2010 Nov; 104(5):955-61. PubMed ID: 20838741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antithrombotic therapy in patients with chronic kidney disease.
    Capodanno D; Angiolillo DJ
    Circulation; 2012 May; 125(21):2649-61. PubMed ID: 22644369
    [No Abstract]   [Full Text] [Related]  

  • 30. Bleeding and venous thromboembolism arising in acutely ill hospitalized medical patients. Findings from the Spanish national discharge database.
    Guijarro R; San Roman C; Arcelus JI; Montes-Santiago J; Gómez-Huelgas R; Gallardo P; Monreal M
    Eur J Intern Med; 2014 Feb; 25(2):137-41. PubMed ID: 24200547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Summaries for patients: nonsteroidal anti-inflammatory drugs and serious bleeding and thromboembolism in patients with atrial fibrillation.
    Ann Intern Med; 2014 Nov; 161(10):I-38. PubMed ID: 25402529
    [No Abstract]   [Full Text] [Related]  

  • 32. [Your patient needs an antithrombotic drug, 9. Atrial fibrillation: unnecessary hesitation regarding anticoagulants?].
    MMW Fortschr Med; 2013 Nov; 155 Spec No 2():24. PubMed ID: 24734444
    [No Abstract]   [Full Text] [Related]  

  • 33. Balancing benefit and bleeding risk of antithrombotic agents in the individual patient with an acute coronary syndrome.
    Van de Werf F
    Circulation; 2010 Jan; 121(1):5-7. PubMed ID: 20026787
    [No Abstract]   [Full Text] [Related]  

  • 34. [NSAID in antithrombotic treatment increases risk of bleeding].
    Holzgreve H
    MMW Fortschr Med; 2015 Mar; 157(4):38. PubMed ID: 25743979
    [No Abstract]   [Full Text] [Related]  

  • 35. Continuation or discontinuation of antithrombotics in clinical daily practice of gastrointestinal endoscopy: Has a paradigm shift occurred in Japan?
    Ono S; Koike K
    Dig Endosc; 2015 Jan; 27(1):16-7. PubMed ID: 25565119
    [No Abstract]   [Full Text] [Related]  

  • 36. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism.
    Tapson VF; Decousus H; Pini M; Chong BH; Froehlich JB; Monreal M; Spyropoulos AC; Merli GJ; Zotz RB; Bergmann JF; Pavanello R; Turpie AG; Nakamura M; Piovella F; Kakkar AK; Spencer FA; Fitzgerald G; Anderson FA;
    Chest; 2007 Sep; 132(3):936-45. PubMed ID: 17573514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stabilizing unstable plaque in acute coronary syndromes: implications for cardiac surgical patients.
    Weber MM; McErlean ES
    Crit Care Nurse; 2000 Aug; 20(4):78-91. PubMed ID: 11876339
    [No Abstract]   [Full Text] [Related]  

  • 38. [Perioperative thrombosis prophylaxis - thrombosis or bleeding - that is the question].
    Ellger B; Van Aken HK
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2012 Apr; 47(4):240-1. PubMed ID: 22504620
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of defibrinating agents ancrod and reptilase in the treatment of thromboembolism.
    Kwaan HC
    Thromb Diath Haemorrh Suppl; 1973; 56():239-51. PubMed ID: 4617331
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical implications and management of bleeding events in patients with acute coronary syndromes.
    De Luca L; Casella G; Lettino M; Fradella G; Toschi V; Conte MR; Ottani F; Geraci G; Visconti LO; Tubaro M; Maggioni AP
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):677-86. PubMed ID: 19531962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.